Aegerion Pharmaceuticals announces second-quarter 2014 financial results
Aegerion reported the 2014 second-quarter GAAP net loss was $9.6 million, or $0.33 per share versus a net loss of $18.9 million for the same period in 2013. Net product sales for the 2014 second-quarter were $36.0 million, compared with $6.5 million in the same 2013 quarter. July 29, 2014